LabCorp 2012 Annual Report Download - page 28

Download and view the complete annual report

Please find page 28 of the 2012 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 54

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54

26
LABORATORY CORPORATION OF AMERICA
Management’s Discussion and Analysis
of Financial Condition and Results of Operations (in millions)
26
LABORATORY CORPORATION OF AMERICA
Consolidated Statements of Changes in Shareholders’ Equity
Accumulated
Additional Other Total
Common Paid-in Retained Treasury Comprehensive Shareholders
(In Millions) Stock Capital Earnings Stock Income (Loss) Equity
Balance at December 31, 2009 $ 12.5 $ 36.7 $ 2,927.9 $ (932.5) $ 61.5 $ 2,106.1
Net earnings attributable to Laboratory
Corporation of America Holdings 558.2 558.2
Other comprehensive earnings, net of tax 27.0 27.0
Issuance of common stock under employee
stock plans 0.2 83.0 83.2
Surrender of restricted stock and performance
share awards (2.4) (2.4)
Conversion of zero-coupon convertible debt 1.1 1.1
Stock compensation 40.0 40.0
Value of noncontrolling interest put (17.2) (17.2)
Income tax benefit from stock options exercised 7.8 7.8
Purchase of common stock (0.5) (97.5) (239.5) (337.5)
Balance at December 31, 2010 $ 12.2 $ 53.9 $ 3,246.6 $ (934.9) $ 88.5 $ 2,466.3
Net earnings attributable to Laboratory
Corporation of America Holdings 519.7 519.7
Other comprehensive earnings, net of tax (43.0) (43.0)
Issuance of common stock under employee
stock plans 0.1 117.9 118.0
Surrender of restricted stock and performance
share awards (6.0) (6.0)
Conversion of zero-coupon convertible debt 0.1 36.1 36.2
Stock compensation 48.9 48.9
Purchase of noncontrolling interest (3.7) (3.7)
Income tax benefit from stock options exercised 11.0 11.0
Purchase of common stock (0.7) (264.1) (379.1) (643.9)
Balance at December 31, 2011 $ 11.7 $ $ 3,387.2 $ (940.9) $ 45.5 $ 2,503.5
Net earnings attributable to Laboratory
Corporation of America Holdings 583.1 583.1
Other comprehensive earnings, net of tax 23.9 23.9
Issuance of common stock under employee
stock plans 0.1 85.1 85.2
Surrender of restricted stock and performance
share awards (10.9) (10.9)
Stock compensation 40.7 40.7
Income tax benefit from stock options exercised 8.4 8.4
Purchase of common stock (0.5) (134.2) (381.8) (516.5)
Balance at December 31, 2012 $ 11.3 $ $ 3,588.5 $ (951.8) $ 69.4 $ 2,717.4
The accompanying notes are an integral part of these consolidated financial statements.